The Effects of Short Message Notifications on Middle-Aged Diabetic Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

125 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-06-30

Study Completion Date

2018-02-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of our study was to assess awareness-raising of medication adherence (MA), physical activity (PA), fasting blood glucose (FBG), and glycated hemoglobin A (HbA1c) values by providing information on diabetes via short message (SMS) technology.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Improving the Activation Level of Diabetic Individuals

NCT06973954

Diabetes Mellitus (DM) Type 2 Diabetes Mellitus (T2DM) Patient Activation +1 more

ACTIVE_NOT_RECRUITING NA

Mobile Phone-based Video Education on Diabetes

NCT05151276

Diabetes Mellitus, Type 2

COMPLETED NA

Teach-Back Educational Method On Diabetes Knowledge Level

NCT04509856

Patient Empowerment

COMPLETED NA

Text Messaging and Cardiovascular Health in Diabetes Mellitus

NCT03724526

Type 2 Diabetes Mellitus

COMPLETED NA

Using a Motivational Interviewing (MI) Informed Text Messaging Program to Lower Blood Sugar in Diabetic Patients.

NCT02012478

Type II Diabetes Mellitus

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study investigates T2DM patients who have not had surgery or cardiac event in the last 3 months, between the ages of 40 and 64 years, with T2DM diagnosis between the last 1 and 10 years and oral antidiabetic therapy for at least 1 The study design is a single-blinded randomized, controlled study, and was conducted in the Diabetes Polyclinic of the Istanbul University Medical Faculty Hospital.

Patients randomly assigned to the intervention group, in addition to traditional treatment received three to four informative SMS messages per week during the 6-month period, while the control group was followed in accordance with the traditional treatment schedule.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type2 Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SMS Group

In addition to traditional treatment received three to four informative SMS messages per week during the 6-month period

Group Type EXPERIMENTAL

Informative messages

Intervention Type OTHER

In addition to their standard treatments, an informative SMS (text message) on diabetes was sent to the intervention group three to four times a week for six months.

The short messages were in the form of a short sentence for the subject and the predicate. The messages sent have been prepared in such a way that they do not exceed 1 SMS quota and are less than 160 characters on mobile phones.

Control Group

Followed in accordance with the traditional treatment schedule

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Informative messages

In addition to their standard treatments, an informative SMS (text message) on diabetes was sent to the intervention group three to four times a week for six months.

The short messages were in the form of a short sentence for the subject and the predicate. The messages sent have been prepared in such a way that they do not exceed 1 SMS quota and are less than 160 characters on mobile phones.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of Type 2 Diabetes Mellitus (T2DM) between the last 1 and 10 years
* Being aged between 40 and 64 years old,
* Is treated for a minimum of 1 year with at least one oral antidiabetic drug.

Exclusion Criteria

* Clinical diagnosis of T2DM for less than 1 year or more than 10 years.
* Those who have had surgery or a cardiac event in the last 3 months or during the investigation.
* Those under 40 and over 64 years of age.
* Patients with T2DM that have not been treated with oral antidiabetic medication.
* Volunteers who once did not participate in the control examinations in both groups were excluded from the evaluation.

Minimum Eligible Age

40 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No